Gustavo Kinrys

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Valproic acid for the treatment of social anxiety disorder
    Gustavo Kinrys
    Massachusetts General Hospital, Boston 02114, USA
    Int Clin Psychopharmacol 18:169-72. 2003
  2. ncbi request reprint An open-label trial of risperidone augmentation for refractory anxiety disorders
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Mass, USA
    J Clin Psychiatry 67:381-5. 2006
  3. ncbi request reprint The combination of duloxetine and bupropion for treatment-resistant major depressive disorder
    George I Papakostas
    Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, Boston, 02114, USA
    Depress Anxiety 23:178-81. 2006
  4. ncbi request reprint Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder
    George I Papakostas
    Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    J Clin Psychiatry 66:1326-30. 2005
  5. doi request reprint Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder
    Mark Pollack
    Massachusetts General Hospital, Simches Research Bldg, 185 Cambridge St, Ste 2200, 2nd Floor, Boston, MA 02114, USA
    Arch Gen Psychiatry 65:551-62. 2008
  6. doi request reprint A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder
    George I Papakostas
    Center for Treatment Resistant Depression, Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychiatry 73:1541-7. 2012
  7. ncbi request reprint Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study
    Mark H Pollack
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, USA
    Biol Psychiatry 59:211-5. 2006
  8. ncbi request reprint Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients
    John J Worthington
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Massachusetts, USA
    Int Clin Psychopharmacol 20:9-11. 2005
  9. ncbi request reprint Bupropion sustained release for panic disorder
    Naomi M Simon
    Department of Psychiatry, Harvard University, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Psychopharmacol Bull 37:66-72. 2003
  10. ncbi request reprint Levetiracetam for treatment-refractory posttraumatic stress disorder
    Gustavo Kinrys
    Anxiety Disorders Research Program, Cambridge Health Alliance, Cambridge, MA 02139, and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA
    J Clin Psychiatry 67:211-4. 2006

Detail Information

Publications15

  1. ncbi request reprint Valproic acid for the treatment of social anxiety disorder
    Gustavo Kinrys
    Massachusetts General Hospital, Boston 02114, USA
    Int Clin Psychopharmacol 18:169-72. 2003
    ..The results from this open-label trial suggest the potential efficacy of valproic acid for the treatment of social anxiety disorder. Placebo-controlled trials are indicated to confirm these findings...
  2. ncbi request reprint An open-label trial of risperidone augmentation for refractory anxiety disorders
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Mass, USA
    J Clin Psychiatry 67:381-5. 2006
    ..There is a paucity of data to support "next-step" treatments for the many patients with anxiety disorders who remain symptomatic after initial pharmacotherapy...
  3. ncbi request reprint The combination of duloxetine and bupropion for treatment-resistant major depressive disorder
    George I Papakostas
    Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, Boston, 02114, USA
    Depress Anxiety 23:178-81. 2006
    ..Although preliminary, these results suggest a possible role for the combination of duloxetine and bupropion for TRD...
  4. ncbi request reprint Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder
    George I Papakostas
    Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    J Clin Psychiatry 66:1326-30. 2005
    ..The purpose of this study was to test this hypothesis in depressed outpatients who have not experienced significant clinical improvement following an adequate trial of a selective serotonin reuptake inhibitor (SSRI)...
  5. doi request reprint Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder
    Mark Pollack
    Massachusetts General Hospital, Simches Research Bldg, 185 Cambridge St, Ste 2200, 2nd Floor, Boston, MA 02114, USA
    Arch Gen Psychiatry 65:551-62. 2008
    ..Insomnia and generalized anxiety disorder (GAD) are prevalent disorders that may coexist...
  6. doi request reprint A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder
    George I Papakostas
    Center for Treatment Resistant Depression, Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychiatry 73:1541-7. 2012
    ..To study ziprasidone monotherapy for major depressive disorder, defined according to the DSM-IV...
  7. ncbi request reprint Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study
    Mark H Pollack
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, USA
    Biol Psychiatry 59:211-5. 2006
    ..We present one of the first randomized controlled trials for refractory GAD, comprising double blind augmentation with olanzapine or placebo for patients remaining symptomatic on fluoxetine...
  8. ncbi request reprint Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients
    John J Worthington
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Massachusetts, USA
    Int Clin Psychopharmacol 20:9-11. 2005
    ..Because this is a retrospective case review, further prospective studies are required to confirm these findings...
  9. ncbi request reprint Bupropion sustained release for panic disorder
    Naomi M Simon
    Department of Psychiatry, Harvard University, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Psychopharmacol Bull 37:66-72. 2003
    ..Although results may be influenced by the open nature of this trial, our findings suggest that bupropion SR may be effective for the treatment of panic disorder. Further controlled study of its efficacy for this condition are warranted...
  10. ncbi request reprint Levetiracetam for treatment-refractory posttraumatic stress disorder
    Gustavo Kinrys
    Anxiety Disorders Research Program, Cambridge Health Alliance, Cambridge, MA 02139, and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA
    J Clin Psychiatry 67:211-4. 2006
    ..To assess the use of levetiracetam, a novel anticonvulsant agent, in the treatment of refractory posttraumatic stress disorder (PTSD)...
  11. ncbi request reprint An open-label study of levetiracetam for the treatment of social anxiety disorder
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychiatry 65:1219-22. 2004
    ..Levetiracetam thus warrants systematic evaluation as a treatment option for anxiety disorders...
  12. ncbi request reprint [Antipsychotics, anticonvulsants, antiadrenergics and other drugs: what to do when posttraumatic stress disorder does not respond to selective serotonin reuptake inhibitors?]
    William Berger
    Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
    Rev Bras Psiquiatr 29:S61-5. 2007
    ....
  13. ncbi request reprint [Anxiety disorders in women: does gender matter to treatment?]
    Gustavo Kinrys
    Programa de Pesquisa dos Transtornos de Ansiedade, Cambridge Health Alliance, Cambridge, MA 02139, USA
    Rev Bras Psiquiatr 27:S43-50. 2005
    ..This article reviews the prevalence, epidemiology, and phenomenology of the major anxiety disorders in women, as well as the implications of such differences for treatment...
  14. ncbi request reprint Anticonvulsants in anxiety disorders
    Gustavo Kinrys
    Anxiety Disorders Research Program, Cambridge Health Alliance Harvard Medical School, Department of Psychiatry, Cambridge, MA 02139, USA
    Curr Psychiatry Rep 7:258-67. 2005
    ..This article reviews past and current research being done in this novel area of psychopharmacology...
  15. ncbi request reprint Levetiracetam as adjunctive therapy for refractory anxiety disorders
    Gustavo Kinrys
    Anxiety Disorders Research Program, Cambridge Health Alliance, Cambridge, MA 02139, USA
    J Clin Psychiatry 68:1010-3. 2007
    ..We present a retrospective analysis that assessed the efficacy and tolerability of adjunctive levetiracetam, a novel anticonvulsant agent, in the treatment of refractory anxiety...